Delipidated Serum in Cell Culture — When and How to Use It

Most researchers associate delipidated serum with IVD assay development. But in cell biology, lipoprotein-free serum is an essential experimental tool — used in LDL receptor upregulation studies, cholesterol biosynthesis research, fatty acid supplementation experiments and any protocol where the lipid content of the serum needs to be controlled rather than variable.

Why Standard Serum Is a Problem in Lipid Research

Standard human serum or FBS contains LDL, HDL, VLDL and triglyceride-rich particles at concentrations that vary substantially between lots. In most cell culture applications, this variability is acceptable because the cells use lipoproteins as a nutrient source without the experiment depending on specific lipid concentrations.

In lipid metabolism research, however, serum lipoproteins are the independent variable. If you are studying how cells regulate LDL receptor expression in response to exogenous LDL, the last thing you want is unpredictable endogenous LDL already present in your serum supplement. Delipidated serum solves this by providing a clean, lipoprotein-free matrix to which you can add back defined lipid species at precise concentrations.

Key Applications in Cell Biology

LDL Receptor Upregulation Studies

The Goldstein and Brown model of LDLR regulation remains a cornerstone of atherosclerosis and cholesterol biology research. To study LDLR upregulation, cells must be deprived of exogenous LDL — causing them to upregulate receptor expression. This requires culturing cells in lipoprotein-free medium, typically DMEM + 5% lipoprotein-deficient serum (LPDS), for 24–48 hours before the experiment.

Delipidated human serum is a practical LPDS source for human cell lines — more physiologically relevant than delipidated FBS when studying human LDLR biology. Standard protocol: culture HepG2 or HEK293 cells in DMEM + 5% delipidated serum for 24 hours, then add defined LDL concentrations and measure LDLR protein expression by Western blot or flow cytometry.

Cholesterol Biosynthesis and HMGCR Studies

HMG-CoA reductase (HMGCR) is the rate-limiting enzyme of the cholesterol biosynthesis pathway and the target of statin drugs. To study HMGCR regulation, cells need to be in a lipoprotein-depleted environment so that de novo synthesis is upregulated and the pathway is active. Culturing cells in delipidated serum activates the SREBP-2/HMGCR axis, making it responsive to statins and cholesterol supplementation in a way that cells in standard serum are not.

Fatty Acid Supplementation Experiments

When studying the effects of specific fatty acids (palmitic, oleic, docosahexaenoic acid etc.) on cell viability, lipotoxicity or membrane composition, researchers need a serum supplement that does not introduce confounding free fatty acids. Delipidated serum provides this — and can be combined with BSA-complexed fatty acids to deliver defined fatty acid species at controlled concentrations.

Lipoprotein-Dependent Cell Signalling

Several signalling pathways are activated by specific lipoprotein particles — oxidised LDL activating LOX-1 in endothelial cells, HDL activating SR-BI-mediated signalling, lipoprotein(a) activating inflammatory pathways. All of these studies require a lipoprotein-free baseline condition.

Protocol: Transitioning Cells to Lipoprotein-Free Medium